These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15245589)

  • 1. Heparanase as a molecular target of cancer chemotherapy.
    Simizu S; Ishida K; Osada H
    Cancer Sci; 2004 Jul; 95(7):553-8. PubMed ID: 15245589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of heparanase inhibitors in cancer therapy.
    Heyman B; Yang Y
    Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the discovery of heparanase inhibitors as anti-cancer agents.
    Jia L; Ma S
    Eur J Med Chem; 2016 Oct; 121():209-220. PubMed ID: 27240275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting heparanase for cancer therapy at the tumor-matrix interface.
    Sanderson RD; Iozzo RV
    Matrix Biol; 2012 Jun; 31(5):283-4. PubMed ID: 22655968
    [No Abstract]   [Full Text] [Related]  

  • 5. Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells.
    Benhamron S; Nechushtan H; Verbovetski I; Krispin A; Abboud-Jarrous G; Zcharia E; Edovitsky E; Nahari E; Peretz T; Vlodavsky I; Mevorach D
    J Immunol; 2006 Jun; 176(11):6417-24. PubMed ID: 16709798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of heparanase inhibitors for anti-cancer therapy.
    Miao HQ; Liu H; Navarro E; Kussie P; Zhu Z
    Curr Med Chem; 2006; 13(18):2101-11. PubMed ID: 16918340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.
    Barash U; Cohen-Kaplan V; Dowek I; Sanderson RD; Ilan N; Vlodavsky I
    FEBS J; 2010 Oct; 277(19):3890-903. PubMed ID: 20840586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase.
    Benezra M; Vlodavsky I; Bar-Shavit R
    Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of heparanase in human tumor cell lines and human head and neck tumors.
    Simizu S; Ishida K; Wierzba MK; Sato TA; Osada H
    Cancer Lett; 2003 Apr; 193(1):83-9. PubMed ID: 12691827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Functions of Heparanase in Human Diseases.
    Jin H; Zhou S
    Mini Rev Med Chem; 2017; 17(6):541-548. PubMed ID: 27804885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
    Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
    BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
    Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
    Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparanase: a target for drug discovery in cancer and inflammation.
    McKenzie EA
    Br J Pharmacol; 2007 May; 151(1):1-14. PubMed ID: 17339837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell surface localization of heparanase on macrophages regulates degradation of extracellular matrix heparan sulfate.
    Sasaki N; Higashi N; Taka T; Nakajima M; Irimura T
    J Immunol; 2004 Mar; 172(6):3830-5. PubMed ID: 15004189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular behavior adapts to context: heparanase functions as an extracellular matrix-degrading enzyme or as a T cell adhesion molecule, depending on the local pH.
    Gilat D; Hershkoviz R; Goldkorn I; Cahalon L; Korner G; Vlodavsky I; Lider O
    J Exp Med; 1995 May; 181(5):1929-34. PubMed ID: 7722469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Heparanase Regulatory Network in Health and Disease.
    Mayfosh AJ; Nguyen TK; Hulett MD
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.
    Bandari SK; Purushothaman A; Ramani VC; Brinkley GJ; Chandrashekar DS; Varambally S; Mobley JA; Zhang Y; Brown EE; Vlodavsky I; Sanderson RD
    Matrix Biol; 2018 Jan; 65():104-118. PubMed ID: 28888912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
    Vlodavsky I; Ilan N; Naggi A; Casu B
    Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New Advances of Heparanase and Heparanase-2 in Human Diseases.
    Jin H; Cui M
    Arch Med Res; 2018 Oct; 49(7):423-429. PubMed ID: 30850186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.